Article

Modeling Continuous Manufacturing Processes

Doug Hausner, associate director at the Engineering Research Center for Structured Organic Particulate Systems (CSOPS) at Rutgers, the State University of New Jersey, spoke with Pharmaceutical Technology at Interphex 2015 about how process modeling fits into the current state of continuous manufacturing of solid-dosage drug products and how modeling can be used to evaluate risk. 

 

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Related Videos
Understanding the Operational Impacts of the 15% US-EU Pharma Tariff Cap
Dave Miller, PhD, Chief Scientific Officer, AustinPx